Andreas von Leupoldt1, Klaus Kenn. 1. Research Group Health Psychology, University of Leuven, Leuven, Belgium. andreas.vonleupoldt@ppw.kuleuven.be
Abstract
PURPOSE OF REVIEW: Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide and is associated with significant individual and socioeconomic burden. Recent research has begun to acknowledge the important role of psychological factors in the course and management of the disease. Therefore, the present review provides an overview on recent findings on psychological factors in COPD with a specific focus on anxiety and depression. RECENT FINDINGS: Recent findings demonstrate high levels of anxiety and depression in COPD patients which are related to a considerably worse course of the disease. The exact causes for these findings are widely unknown, but several potential mechanisms have been suggested. Moreover, anxiety and depression often remain undetected and untreated in COPD patients. Although some beneficial effects of respective psychotropic and psychotherapeutic treatments have been reported, future well-controlled studies regarding their efficacy are mandatory. SUMMARY: Comorbid anxiety and depression in patients with COPD are a major health problem requiring intensified research activities. Future studies need to examine the exact links between COPD and these psychological comorbidities, and how their detection and treatment can be improved in the clinical setting.
PURPOSE OF REVIEW: Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide and is associated with significant individual and socioeconomic burden. Recent research has begun to acknowledge the important role of psychological factors in the course and management of the disease. Therefore, the present review provides an overview on recent findings on psychological factors in COPD with a specific focus on anxiety and depression. RECENT FINDINGS: Recent findings demonstrate high levels of anxiety and depression in COPDpatients which are related to a considerably worse course of the disease. The exact causes for these findings are widely unknown, but several potential mechanisms have been suggested. Moreover, anxiety and depression often remain undetected and untreated in COPDpatients. Although some beneficial effects of respective psychotropic and psychotherapeutic treatments have been reported, future well-controlled studies regarding their efficacy are mandatory. SUMMARY: Comorbid anxiety and depression in patients with COPD are a major health problem requiring intensified research activities. Future studies need to examine the exact links between COPD and these psychological comorbidities, and how their detection and treatment can be improved in the clinical setting.
Authors: Muirne C S Paap; Christina Bode; Lonneke I M Lenferink; Caroline B Terwee; Job van der Palen Journal: Qual Life Res Date: 2014-11-16 Impact factor: 4.147
Authors: Hoi Nam Tse; Cee Zhung Steven Tseng; King Ying Wong; Lai Yun Ng; Tin Lok Lai; Kwok Sang Yee Journal: Lung Date: 2016-05-02 Impact factor: 2.584
Authors: Adam Lewis; Phoene Cave; Myra Stern; Lindsay Welch; Karen Taylor; Juliet Russell; Anne-Marie Doyle; Anne-Marie Russell; Heather McKee; Stephen Clift; Julia Bott; Nicholas S Hopkinson Journal: NPJ Prim Care Respir Med Date: 2016-12-01 Impact factor: 2.871
Authors: Jesús Recio Iglesias; Jesús Díez-Manglano; Francisco López García; José Antonio Díaz Peromingo; Pere Almagro; José Manuel Varela Aguilar Journal: Int J Chron Obstruct Pulmon Dis Date: 2020-05-07
Authors: Muirne C S Paap; Christina Bode; Lonneke I M Lenferink; Lianne C Groen; Caroline B Terwee; Sara Ahmed; Owis Eilayyan; Job van der Palen Journal: Health Qual Life Outcomes Date: 2014-07-09 Impact factor: 3.186
Authors: Harvey Max Chochinov; Wendy Johnston; Susan E McClement; Thomas F Hack; Brenden Dufault; Murray Enns; Genevieve Thompson; Mike Harlos; Ronald W Damant; Clare D Ramsey; Sara Davison; James Zacharias; Doris Milke; David Strang; Heather J Campbell-Enns; Maia S Kredentser Journal: PLoS One Date: 2016-01-25 Impact factor: 3.240